Oncimmune Holdings PLC (ONC)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

25.00p

Buy

25.60p

arrow-down-0.30p (-1.17%)

Prices updated at 24 May 2024, 12:30 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Oncimmune Holdings PLC is a cancer detection company engaged in developing and commercializing its proprietary EarlyCDT platform technology. Its product EarlyCDT-Lung is a simple blood test to aid the risk assessment and early detection of lung cancer.
FTSE All-Share
arrow-down-0.13%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
25.60
triangle-d
arrow-down
-0.57 (-2.23%)
triangle-d
Today open
25.03
triangle-d
arrow-up
0.27 (+1.08%)
triangle-d
Today, 12:30:59 BST
25.30
triangle-d
25.03p - 25.03p
38.35p - 13.00p
-
18.76m
-
10,000
16,550
-
76,215.03
1.73
74.14m
GB00BYQ94H38
0.11
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.